National Gun Association

ALL SITE LINKS ARE ON OUR HOME PAGE _ CLICK ON RED BAR 

Copyright 2013. national gun association. All Rights Reserved.

YOU JUST PASSED THE VIRUS 

CDC Cruise Ship Travel March 17 2020 



No. Article I of the Biological Weapons Convention

SUPER VIRUS - SUPER BUGS - CLIMATE CHANGE

Special Focus on Covid-19 

Ignorance and Arrogance have brought down nations!



Spain receives 500,000 masks as part of China's first aid package


Government of Spain will allocate 200 billion euros to combat Covid-19

March , 17 , 2020



On the origin and continuing evolution of SARS-CoV-2


Did the report provide a “blueprint” for bioterrorists to develop and unleash a devastating pandemic on the world?

No. This report does not provide the blueprint for bioterrorist to develop a pandemic influenza strain. The reverse genetics system that was used to generate the 1918 virus is a widely used laboratory technique. While there are concerns that this approach could potentially be misused for purposes of bioterrorism, there are also clear and significant potential benefits of sharing this information with the scientific community: namely, facilitating the development of effective interventions, thereby strengthening public health and national security.

Is the 1918 influenza virus a select agent? The Intra-governmental Select Agents and Toxins Technical Advisory Committee convened on September 30, 2005, and recommended that the reconstructed 1918 influenza virus be added to the list of HHS select agents. Following this recommendation, CDC amended its regulations and designated all reconstructed replication competent forms of the 1918 pandemic influenza virus containing any portion of the coding regions of all eight gene segments (reconstructed 1918 Influenza virus) as a select agent.

What is the Select Agent Program? The Centers for Disease Control and Prevention (CDC) regulates the possession, use and transfer of select agents and toxins that have the potential to pose a severe threat to public health and safety. The CDC Select Agent Program oversees these activities and registers all laboratories and other entities in the United States of America that possess, use or transfer a select agent or toxin.

The U.S. Departments of Health and Human Services (HHS) and Agriculture (USDA) published final rules for the possession, use, and transfer of select agents and toxins (42 C.F.R. Part 73, 7 C.F.R. Part 331, and 9 C.F.R. Part 121) in the Federal Register on March 18, 2005. All provisions of these final rules supersede those contained in the interim final rules and became effective on April 18, 2005.

Who funded the work described in this article? Work with the reconstructed 1918 virus was conducted at and supported by CDC. The U.S. Department of Agriculture (USDA), the National Institutes of Health (NIH), and the Armed Forces Institute of Pathology (AFIP) all provided support for many other aspects of this research.

When did CDC begin research on the 1918 virus? CDC studies of the 1918 influenza virus were begun in 2004 with the initiation of testing of viruses containing subsets of the eight genes of the 1918 virus. Previous articles describing the properties of such viruses were published before 2005. Reconstruction of the entire 1918 virus was begun in August 2005.

Could a 1918-like H1N1 virus re-emerge and cause a pandemic again? It is impossible to predict with certainty the emergence of a future pandemic, including a 1918-like virus. Pandemics occur when an influenza virus emerges to which there is little, or no, preexisting immunity in the human population. However, it is generally thought that a 1918-like pandemic would be less severe due to the advent of vaccines to prevent flu, current FDA-approved antiviral influenza drugs, and the existing global influenza surveillance system that the World Health Organization maintains.

Are current antivirals and vaccines effective against the 1918 H1N1 virus?

Yes. Oseltamivir (Tamiflu® or generic), has been shown to be effective against similar influenza A(H1N1) viruses and is expected to be effective against the 1918 H1N1 virus. Other antivirals (zanamivir, peramivir and baloxavir) have not been tested against this specific virus but are expected to also be effective. Vaccines containing the 1918 HA or other subtype H1 HA proteins were effective in protecting mice against the 1918 H1N1 virus. Vaccination with current seasonal influenza vaccines is expected to provide some protection in humans since seasonal influenza vaccines provided some level of protection against the 1918 H1N1 virus in mice.

Are new prophylactics and therapeutics that could be effective against the 1918 virus under way? Scientists continue to work on development of new antivirals which may be effective against a 1918-like virus. The reconstruction of the 1918 H1N1 pandemic virus and subsequent studies that followed showed that the 1918 polymerase genes contribute to efficient replication of the pandemic virus. This insight identified an important virulence factor in the study of influenza that is now targeted for antiviral compound development. Therefore, new polymerase inhibitors promise to add to the clinical management options against influenza virus infections in the future.

Biosafety Precautions

Was the public at risk from the experiments being done on this virus?

The work described in this report was done using stringent biosafety and biosecurity precautions that are designed to protect workers and the public from possible exposure to this virus (for example, from accidental release of the virus into the environment). The 1918 virus used in these experiments has since been destroyed at CDC and does not pose any ongoing risk to the public.

What biosafety and biosecurity precautions for protecting laboratory workers and the public were in place while this work was being done?

Before the experiments were begun, two tiers of internal CDC approval were conducted: an Institutional Biosafety Committee review and an Animal Care and Use Committee review. All viruses containing one or more gene segments from the 1918 influenza virus were generated and handled in accordance with biosafety guidelines of the Interim CDC-NIH Recommendation for Raising the Biosafety Level Laboratory Work Involving Noncontemporary Human Influenza Viruses. Although the 1918 virus was not designated as a select agent at the time this work was performed, all procedures were carried out using the heightened biosecurity elements mandated by CDC’s Select Agent program. The Intra-governmental Select Agents and Toxins Technical Advisory Committee recommended that the reconstructed 1918 influenza virus be added to the list of HHS select agents on September 30, 2005. Following this recommendation, CDC amended its regulations and designated all reconstructed replication competent forms of the 1918 pandemic influenza virus containing any portion of the coding regions of all eight gene segments (reconstructed 1918 Influenza virus) as a select agent.

What are the appropriate biosafety practices and containment conditions for work with the 1918 strain of influenza? Biosafety Level 3 or Animal Biosafety Level 3 practices, procedures and facilities, plus enhancements that include special procedures (discussed in the next question below), are recommended for work with the 1918 strain. There are four biosafety levels that correspond to the degree of risk posed by the research and involve graded levels of protection for personnel, the environment, and the community. Biosafety Level 4 provides the most stringent containment conditions, Biosafety Level 1 the least stringent. These biosafety levels consist of a combination of laboratory practices and techniques, safety equipment, and laboratory facilities that are appropriate for the operations being performed. The specific criteria for each biosafety level are detailed in the CDC/NIH publication Biosafety in Microbiological and Biomedical Laboratories.

What is Biosafety Level 3 “enhanced”? What are the specific enhancements used for work with the 1918 strain of influenza? A Biosafety Level 3 facility with specific enhancements includes primary (safety cabinets, isolation chambers, gloves and gowns) and secondary (facility construction, HEPA filtration treatment of exhaust air) barriers to protect laboratory workers and the public from accidental exposure. The specific additional (“enhanced”) procedures used for work with the 1918 strain include:

Rigorous adherence to additional respiratory protection and clothing change protocols;

Use of negative pressure, HEPA-filtered respirators or positive air-purifying respirators (PAPRs);

Use of HEPA filtration for treatment of exhaust air; and Amendment of personnel practices to include personal showers prior to exiting the laboratory.

Further details of the biosafety recommendations for work with various human and animal influenza viruses, including 1918 virus, can be found in the interim CDC/NIH guidance for such work at Interim CDC-NIH Recommendation for Raising the Biosafety Level Laboratory Work Involving Noncontemporary Human Influenza Viruses.

How were these experiments conducted safely using containment provided by BSL-3 with enhancements?br>
Highly trained laboratorians worked with the 1918 influenza virus strain safely using BSL-3-enhanced containment. Researchers at CDC receive specialized training and go through a rigorous biosafety (and security) clearance process. For the work reported in the Science article, the lead CDC researcher provided routine weekly written reports to CDC management officials, including the agency’s Chief Science Officer, and was instructed to notify agency officials immediately of any concerns related to biosafety or biosecurity.

A BSL-3 facility with specific enhancements includes primary (safety cabinets, isolation cabinets, gloves, gowns) and secondary (facility construction) barriers to protect laboratory workers and the public from accidental exposure. Specific enhancements include change-of-clothing and shower-out requirements, and the use of a powered air purifying respirator (PAPR; half body suits). The primary and secondary barriers plus additional personal safety practices provide appropriate containment for conducting such influenza research. CDC evaluated the specific studies to be conducted as well as the highly experienced scientific team conducting the research and concluded that this work could proceed under BSL-3 containment with enhancements.

Why was BSL-3-enhanced containment used for work on the 1918 H1N1 virus when most human influenza viruses of the H1N1 subtype are handled under much less stringent containment? The appropriate biosafety measures for working a given pathogen depend upon a number of factors, including previous experience with the pathogen or similar pathogens, the virulence and transmissibility of the pathogen, the type of experiment, and the availability of vaccines and/or antimicrobial drugs effective against the pathogen. Prior to reconstruction of the 1918 virus, CDC carefully evaluated the specific studies to be conducted and concluded that this research could safely and securely be done under BSL-3-enhanced containment. All viruses containing one or more gene segments from the 1918 influenza virus were generated and handled under high-containment (BSL 3-enhanced) laboratory conditions in accordance with guidelines of NIH and CDC. The recommendations for biosafety levels are made by a panel of experts and are followed in a stringent manner.

A higher level of containment (biosafety level 4) is utilized for work on novel or exotic pathogens for which there is no treatment or vaccine. This is not the case for the 1918 virus. Descendants of the 1918 influenza virus still circulate today, and current seasonal influenza vaccines provide some protection against the 1918 virus. In addition, two types of antiviral drugs, rimantadine (Flumadine) and oseltamivir (Tamiflu® or generic) have been shown to be effective against similar influenza A(H1N1) viruses and are expected to be effective against the 1918 H1N1 virus. Other antivirals (zanamivir, peramivir and baloxavir) have not been tested against this specific virus but also are expected to be effective.

The physical and engineering design of BSL-3-enhanced containment is very similar to that used in BSL-4 laboratories. The BSL-3 laboratory also has state-of-the-art directional airflow control which filters outgoing air, and all waste is autoclaved or decontaminated before it leaves the work area, preventing escape of infectious agents.

Biosecurity Issues

Did the generation of the 1918 Spanish influenza pandemic virus containing the complete coding sequence of the eight viral gene segments violate the Biological Weapons Convention? No. Article I of the Biological Weapons Convention (BWC) specifically allows for microbiological research for prophylactic, protective, or other peaceful purposes. Article X of the BWC encourages the “fullest possible exchange of…scientific and technological information” for the use of biological agents for the prevention of disease and other peaceful purposes. Further, Article X of the BWC provides that the BWC should not hamper technological development in the field of peaceful bacteriological activities. Because the emergence of another pandemic virus is considered likely, if not inevitable, characterization of the 1918 virus may enable us to recognize the potential threat posed by new influenza virus strains, and it will shed light on the prophylactic and therapeutic countermeasures that will be needed to control pandemic viruses.

Did the report provide a “blueprint” for bioterrorists to develop and unleash a devastating pandemic on the world? No. This report does not provide the blueprint for bioterrorist to develop a pandemic influenza strain. The reverse genetics system that was used to generate the 1918 virus is a widely used laboratory technique. While there are concerns that this approach could potentially be misused for purposes of bioterrorism, there are also clear and significant potential benefits of sharing this information with the scientific community: namely, facilitating the development of effective interventions, thereby strengthening public health and national security.

Is the 1918 influenza virus a select agent? The Intra-governmental Select Agents and Toxins Technical Advisory Committee convened on September 30, 2005, and recommended that the reconstructed 1918 influenza virus be added to the list of HHS select agents. Following this recommendation, CDC amended its regulations and designated all reconstructed replication competent forms of the 1918 pandemic influenza virus containing any portion of the coding regions of all eight gene segments (reconstructed 1918 Influenza virus) as a select agent.

What is the Select Agent Program? The Centers for Disease Control and Prevention (CDC) regulates the possession, use and transfer of select agents and toxins that have the potential to pose a severe threat to public health and safety. The CDC Select Agent Program oversees these activities and registers all laboratories and other entities in the United States of America that possess, use or transfer a select agent or toxin.

The U.S. Departments of Health and Human Services (HHS) and Agriculture (USDA) published final rules for the possession, use, and transfer of select agents and toxins (42 C.F.R. Part 73, 7 C.F.R. Part 331, and 9 C.F.R. Part 121) in the Federal Register on March 18, 2005. All provisions of these final rules supersede those contained in the interim final rules and became effective on April 18, 2005.

​Bio Hazards Domestic and Foreign Threats



Did the generation of the 1918 Spanish influenza pandemic virus containing the complete coding sequence of the eight viral gene segments violate the Biological Weapons Convention? No. Article I of the Biological Weapons Convention (BWC) specifically allows for microbiological research for prophylactic, protective, or other peaceful purposes. Article X of the BWC encourages the “fullest possible exchange of…scientific and technological information” for the use of biological agents for the prevention of disease and other peaceful purposes. Further, Article X of the BWC provides that the BWC should not hamper technological development in the field of peaceful bacteriological activities. Because the emergence of another pandemic virus is considered likely, if not inevitable, characterization of the 1918 virus may enable us to recognize the potential threat posed by new influenza virus strains, and it will shed light on the prophylactic and therapeutic countermeasures that will be needed to control pandemic viruses.

What is Biosafety Level 3 “enhanced”? What are the specific enhancements used for work with the 1918 strain of influenza? A Biosafety Level 3 facility with specific enhancements includes primary (safety cabinets, isolation chambers, gloves and gowns) and secondary (facility construction, HEPA filtration treatment of exhaust air) barriers to protect laboratory workers and the public from accidental exposure. The specific additional (“enhanced”) procedures used for work with the 1918 strain include:

Rigorous adherence to additional respiratory protection and clothing change protocols;

Use of negative pressure, HEPA-filtered respirators or positive air-purifying respirators (PAPRs);

Use of HEPA filtration for treatment of exhaust air; and Amendment of personnel practices to include personal showers prior to exiting the laboratory.

Further details of the biosafety recommendations for work with various human and animal influenza viruses, including 1918 virus, can be found in the interim CDC/NIH guidance for such work at Interim CDC-NIH Recommendation for Raising the Biosafety Level Laboratory Work Involving Noncontemporary Human Influenza Viruses.



Fight the 2019-nCoV virus and support technological breakthroughs, we are in action!


The President of the Spanish Government, Pedro Sánchez , announced on Tuesday the mobilization of 200,000 million euros, almost 20% of GDP, to combat the economic effects of the coronavirus epidemic, international media reported.

During a press conference after the Council of Ministers, Sánchez highlighted that, of this amount, "the largest mobilization of economic resources in the recent history of Spain", 117,000 million will be "entirely public" and the rest, private.

This, together with the contraction in demand, has caused many citizens to be losing their income: some, because their business is no longer active, and others, because the companies they work for are beginning to process Temporary Employment Regulation Files .

According to Fernando Simón, director of the Center for Coordination of Health Alerts and Emergencies (CCAES) of the Spanish Ministry of Health, in the last 24 hours, a thousand 987 new cases have been detected, so that the total number of positives amounts to 11 thousand 178 cases in the country. / CP

March 17, 2020 



They discover that malaria medication inhibits coronavirus infection Caracas, February 6, 2020 VTV

Chinese scientists have discovered that chloroquine, a drug against malaria, can effectively inhibit infection with the new coronavirus "in vitro," specialized media reported.

According to information disseminated by experts from the Wuhan Institute of Virology of the Chinese Academy of Sciences and the Beijing Institute of Pharmacology and Toxicology, chloroquine has shown an antiviral effect in the entry and post-entry stages of the new infection. coronavirus in Vero E6 cells. These cells, extracted from the kidney of an African green monkey, are one of the most used mammalian cell lines in microbiology and molecular and cellular biology research.

Previously it was known that chloroquine, a drug widely used against malaria and immune system diseases, blocks virus infections by changing the value of acidity and basicity within the cell and interfering between the coronavirus receptors that cause SARS.

In the study, the drug also showed immunomodulatory activity, which may improve its antiviral effect "in vivo."

The drug is widely distributed throughout the body, including the lungs, after oral administration, the researchers said.

They also indicated that chloroquine is a safe and low-cost medication that has been used for more than 70 years, and could be clinically applicable against the new coronavirus. / CP



Cuban doctor confirms that Venezuela has effective sanitary measures to eradicate Covid-19


United States Constitution Article 1 Section 8 Promote Science


The first package of donations from China to Spain, consisting of 500,000 masks, arrived Tuesday at the airport in the city of Zaragoza, in the northeast of Spain, as part of the first aid package, international media reported.

This aid has been provided by the Jack Ma Foundation and the Alibaba Foundation and was received by the Spanish Ministry of Health with the aim of helping to combat the crisis due to the disease of the new coronavirus (Covid-19) that affects the European country.

On March 14, the Spanish government declared a state of alert to the growing number of coronavirus infections.

The Ministry of Health, Consumption and Social Welfare of Spain announced on Tuesday that the number of cases of Covid-19 registered so far since the start of the outbreak reached 11,178 and 491 deaths. / CP



A health worker uses a thermal scanner on a man with temperature higher than normal in an isolated makeshift room at a checkpoint at the border of Rizal Province and Quezon City, the Philippines on March 17, 2020. Philippine President Rodrigo Duterte on Monday placed the entire Luzon island in the Philippines under the "enhanced community quarantine" to curb the spread of COVID-19. (Xinhua/Rouelle Umali)

LINKS 



The SARS-CoV-2 epidemic started in late December 2019 in Wuhan, China, and has since impacted a large portion of China and raised major global concern. Herein, we investigated the extent of molecular divergence between SARS-CoV-2 and other related coronaviruses. Although we found only 4% variability in genomic nucleotides between SARS-CoV-2 and a bat SARS-related coronavirus (SARSr-CoV; RaTG13), the difference at neutral sites was 17%, suggesting the divergence between the two viruses is much larger than previously estimated. Our results suggest that the development of new variations in functional sites in the receptor-binding domain (RBD) of the spike seen in SARS-CoV-2 and viruses from pangolin SARSr-CoVs are likely caused by mutations and natural selection besides recombination. Population genetic analyses of 103 SARS-CoV-2 genomes indicated that these viruses evolved into two major types (designated L and S), that are well defined by two different SNPs that show nearly complete linkage across the viral strains sequenced to date. Although the L type (∼70%) is more prevalent than the S type (∼30%), the S type was found to be the ancestral version. Whereas the L type was more prevalent in the early stages of the outbreak in Wuhan, the frequency of the L type decreased after early January 2020. Human intervention may have placed more severe selective pressure on the L type, which might be more aggressive and spread more quickly. On the other hand, the S type, which is evolutionarily older and less aggressive, might have increased in relative frequency due to relatively weaker selective pressure. These findings strongly support an urgent need for further immediate, comprehensive studies that combine genomic data, epidemiological data, and chart records of the clinical symptoms of patients with coronavirus disease 2019 (COVID-19).

PDF FILES - SCIENCE LINKS - SUPPLY LINKS AND MORE 



Photo taken on March 17, 2020 shows a closed Starbucks shop in Istanbul, Turkey. The country has announced the closure of all coffee shops from the evening of March 16, as a measure to curb the spread of the novel coronavirus. (Xinhua/Xu Suhui)

We are a coalition Of Survivalist and Environmentalist/Scientist 

       

                    Never Underestimate those with knowledge 



The Executive Vice President of the Bolivarian Republic of Venezuela, Delcy Rodríguez from the Presidential Command Post , installed in the Miraflores Palace, announced that the Bolivarian Government is conducting an exchange with expert epidemiologists to face the Covid-19 pandemic .

The information was provided after the meeting with the Presidential Commission for the Prevention of Covid-19 , where he explained that these actions are carried out to inform epidemiological experts, "On the scientific basis to break the chain of transmission of the coronavirus, same that have welcomed the measures implemented by Venezuela, "he said.

He also mentioned that there is a delegation of Cuban expert doctors in the country and Dr. Luis Herrera, creator of the drug Interferón "In our meetings, we have developed the method of applying the drug."

They will carry out a survey of the Homeland Platform

Vice President Delcy Rodríguez also reported that a survey will be carried out through the Homeland Platform, which will allow the Venezuelan State to know the health conditions of each of the country's inhabitants and thus to know “The possible incidence sites and health conditions of our people, "he said.

Finally, he celebrated the civility with which the Venezuelan people adopted the measures of protection and containment of the expansion of the Covid-19 "We congratulate for the high civic awareness, principle of solidarity, the measures that we adopt is not only for the country but for all The humanity".



The Cuban doctor, Luis Herrera , confirmed that Venezuela has strict effective sanitary measures and an organizational capacity to eradicate Covid-19 undertaken by the National Government through social quarantine.

During an interview with the multistate Telesur, the Cuban scientist said: "Venezuela acted in time to avoid further contagion of the coronavirus, Interferon will not prevent people from being infected, so isolation measures must be taken."

Also, the creator of the drug that has been successful to the population of the People's Republic of China reported that Interferon is a protein, and does not act directly against Covid-19 but promotes defense mechanisms in cells, thus avoiding let the virus take hold.

"Interferon is not a vaccine, but it is important to strengthen human cells and defend against the coronavirus," said the scientist.

On the other hand, Dr. Herrera stated that these coronavirus epidemics occur regularly, previously it was H1N1, it was also treated with the aforementioned drug. "Interferon is used with 21 other medications that serve to decrease the ravages of Covid-19."



Bolivarian Government exchanges experiences with expert epidemiologists to face Covid-19

03 / March / 2020

Russia Traveler View CDC 

​Bio Hazards Domestic and Foreign Threats



Warning - Level 3, Avoid Nonessential

Travel—Widespread Ongoing Transmission

National Science Review / Oxford



A Yemeni worker makes masks at a sewing factory in Sanaa, Yemen, March 17, 2020. (Photo by Mohammed Mohammed/Xinhua)


French President Emmanuel Macron is pictured at a televised address to the nation in Paris, France, March 16, 2020. French President Emmanuel Macron on Monday widened steps already taken to fight "a sanitary war" against the COVID-19 pandemic, ordering border closures, air traffic suspension, tougher restriction on movements and also penalties for offenders. (Xinhua/Gao Jing)


A Kazakh woman wears face mask in Nur-Sultan, Kazakhstan, on March 16. 2020. Kazakhstan began a one-month state of emergency to curb the spread of COVID-19 on Monday. It bans travellers, except diplomats and those invited by the government, from entering or leaving Kazakhstan by all means of transport. All public events are also suspended. (Photo by Kalizhan Ospanov/Xinhua)

Do NOT Bump Elbows 

Travel Restrictions Learn What Others Are Doing

National Science Review 



  At present, the people of the whole country are working together to fight the epidemic, and the national emergency prevention and control work has also called for more scientific and technological workers to participate. With the support of the Wuhan Library and Information Center of the Chinese Academy of Sciences in the Library and Information Center of the Chinese Academy of Sciences, it actively exerts its business expertise and quickly builds support services. It strives to fight the 2019-nCoV virus, support scientific research, and make its due contributions.

  1. Carry out 2019-nCoV scientific research dynamic monitoring and provide the latest scientific clues

  " 2019-nCoV Scientific Research Dynamic Monitoring" was jointly launched by the Wuhan Documentation and Information Center of the Chinese Academy of Sciences and the Documentation and Information Center of the Chinese Academy of Sciences. This service aims to provide reference for China's scientific research and related scientific research by providing the latest scientific research clues and extracting the main content of scientific research papers.

  If you need to know about 2019-nCoV the latest scientific developments, Download 2019-nCoV Research Letters, retrieving 2019-nCov research database, visit the following services.

  ( 1 ) 2019-nCoV latest scientific research dynamic and relevant research questions Data Compilation

  http://stm.las.ac.cn/STMonitor/qbwnew/openhome.htm?serverId=172

  ( 2 ) 2019-nCoV daily scientific bulletin and irregular accumulation data, all open for download

  http://stm.las.ac.cn/STMonitor/qbwnew/cyjb.htm?parentPageId=1580803621111&serverId=172

  ( 3 ) 2019-nCoV research paper data retrieval

  http://ncovdata.whlib.ac.cn/admin/reportinfo/reportInfo/reportList.html

  ( 4 ) through the " China Science News " published compilations Daily Express and cumulative micro-channel public number

   Search “China Science News”, “ Sci-think ” on WeChat or scan the following QR code to follow WeChat public account. That is to say, the " 2019-nCov Scientific Monitoring Daily Newsletter " and accumulated data compilation can be obtained .

     ( 5 ) Introduce the policy topic of “ Countering New Coronavirus Epidemic Situation ” and follow up on policy measures in a timely manner

  http://gopolicy.las.ac.cn/service/prpro?dbid=1&px=oapdate

2.Promote the WEBVPN service of the center of the institute to solve the remote document acquisition of scientific researchers

During the epidemic, the Chinese Academy of Sciences Documentation and Information Center opened a remote service for 17 digital academic resources ordered by the entire institute. Researchers at the Chinese Academy of Sciences can log in and authenticate through their email accounts at the Chinese Academy of Sciences at home or elsewhere, and can retrieve and download the full text remotely.

  See details.

  http://www.whlib.ac.cn/ver/hm/xinwzx/tzgg/news1/202002/t20200206_5497536.html

3. Systematic collection and arrangement of free academic resources related to new coronavirus pneumonia

Collect and organize free academic resources related to new coronavirus pneumonia and free academic resources in comprehensive fields through various channels (including databases, publishers, Internet company websites, WeChat public accounts, peer websites, etc.), and provide homes for the majority of "homes" at home The scientific research community and the general public provide professional and authoritative resource guarantees to help scientific research.

See details.

http://www.whlib.ac.cn/ver/hm/xinwzx/tzgg/news1/202002/t20200208_5497822.html

  4. Serve the original needs of 2019-nCoV researchers through NSTL East Lake Service Station

  2 Yue 3 Ri Zhi 4 Yue 30 Ri, NSTL Wuhan Donghu service station will fight the novel coronavirus work of researchers provide the relevant scientific literature free service.

  Contact Email: dclt@mail.whlib.ac.cn

  Phone: 15342348126 .

  5, launched the 2019-nCoV scientific knowledge compiled for the public understanding of the relevant knowledge

  http://www.whlib.cas.cn/ver/hm/kxpj/kpzs/202002/t20200203_5496989.html



Philippines expands lockdown to include entire Luzon island to contain COVID-19


3/12/2020 ::::: Kiev imposes restrictions on schools, public events due to coronavirus

"Blueprint" For Bio-Terrorist CDC Website